Primary Extranodal Non-Hodgkin's Lymphoma in Adults: Clinicopathological and Survival Characteristics

References

• Epstein J. Myeloma phenotype: Clues to disease origin and manifestation. Hematol. Oncol. Clin. North. Am 1992; 6: 249–256
   PubMed Web of Science ®Google Scholar
• Kubagawa H., Vogler L. B., Capla J. D., Conrad M. E., Lawton A. R., Cooper M. D. Studies on the clonal origin of multiple myeloma. J. Exp. Med 1979; 150: 792–807
   PubMed Web of Science ®Google Scholar
• Pettersson D., Mellstedt H., Holm G. Monoclonal B lymphocytes in multiple myeloma. Scand. J. Immunol 1980; 12: 375–382
   PubMed Web of Science ®Google Scholar
• Shimazaki C., Gotoh H., Oku N., Inaba T., Murakami S., Oku N., Itoh K., Ura Y., Nakagawa M., Fujita N. Detection of minimal residual myeloma cells by dual parameter analysis of DNA and cytoplasmic immunoglobulin. Acta Haematol 1991; 85: 20–25
   PubMed Web of Science ®Google Scholar
• Shimazaki C., Fried J., Perez A. G., Scheinberg D. A., Atzpodien J., Wang C. Y., Wisniewolski R., Clarkson B. D. Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myeloma. Acta Haematol 1990; 83: 123–129
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F., Bergui L., Tesio L., Pizzolo G., Malavasi F., Chilosi M., Campana D., Van Camp B., Janossy G. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. J. Clin. Invest 1985; 76: 1243–1251
   PubMed Web of Science ®Google Scholar
• Grogan T. M., Durie B. G. M., Lomen C., Spier C., Wirt D. P., Nagle R., Wilson G. S., Richter L., Vera E., Maxey V., McDaniel K., Rangel C. Delineation of a novel pre-B cell component in plasma cell myeloma: Immunological, immunophenokinetic, genotypic, cytologic, cell culture, and kinetic features. Blood 1987; 70: 932–942
   PubMed Web of Science ®Google Scholar
• Epstein J., Barlogie B., Katzmann J., Alexanian R. Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvement. Blood 1988; 71: 861–865
   PubMed Web of Science ®Google Scholar
• Berenson J., Wong R., Kim K., Brown N., Lichtenstein A. Evidence for peripheral blood B lymphocyte but not T-lymphocyte involvement in multiple myeloma. Blood 1987; 70: 1550–1553
   PubMed Web of Science ®Google Scholar
• Chiu E. K. W., Gasneshaguru K., Hoffbrand A. V., Mehta A. B. Circulating monoclonal B lymphocytes in multiple myeloma. Br. J. Haemat 1989; 72: 28–31
   PubMed Web of Science ®Google Scholar
• van Reit I., Heirman C., Lacor P., De Waele M., Thielemans K., van Camp B. Detection of monoclonal B lymphocytes in bone marrow and peripheral blood of multiple myeloma patients by immunoglobulin gene rearrangement studies. Br. J. Haematol 1989; 73: 289–295
   PubMed Web of Science ®Google Scholar
• Billadeau D., Quam L., Thomas W., Kay N., Greipp P., Kyle R., Oken M. M., Van Ness B. Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood 1992; 80: 1818–1824
   PubMed Web of Science ®Google Scholar
• Kawano M., Hirano T., Matsuda T., Taga T., Horii Y., Asaoku H., Tang B., Tanabe O., Tanaka H., Kuramoto A., Kishimoto T. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 1988; 332: 83–85
   PubMed Web of Science ®Google Scholar
• Klein B., Zhang X. G., Jourdan M., Content J., Houssiau F., Aarden L., Piechaczyk M., Bataille R. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 1989; 73: 517–526
   PubMed Web of Science ®Google Scholar
• Zhang X. G., Bataille R., Jourdan M., Saeland S., Banchereau J., Mannoni P., Klein B. Granulocyte-macrophage colony stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells. Blood 1990; 72: 2599–2605
   Google Scholar
• Sawamura M., Murakami H., Tamura J., Matsushima T., Sato S., Naruse T., Tsuchiya J. Tumour necrosis factor-α and interleukin 4 promote the differentiation of myeloma cell precursors in multiple myeloma. Br. J. Haematol 1994; 88: 17–23
   PubMed Web of Science ®Google Scholar
• Durie B. G. M., Salmon S. E. A clinical staging system for multiple myeloma. Cancer 1975; 36: 842–854
   PubMed Web of Science ®Google Scholar
• Lichtenstein A., Berenson J., Norman D., Chang M. P., Carlile A. Production of cytokines by bone marrow cells obtained from patients with multiple myeloma. Blood 1989; 74: 1266–73
   PubMed Web of Science ®Google Scholar
• Carter A., Merchav S., Silvian-Draxler I., Tatarsky I. The role of interleukin-1 and tumour necrosis factor-alpha in human multiple myeloma. Br. J. Haematol 1990; 74: 424–431
   PubMed Web of Science ®Google Scholar
• Hata H., Matsuzaki H., Takatsuki K. Autocrine growth by two cytokines, interleukin-6 and tumor necrosis factor alpha, in the myeloma cell line KHM-1A. Acta Haemat 1990; 83: 133–136
   PubMed Web of Science ®Google Scholar
• Sonneveld P., Schoester M., de Leeuw K. In vitro Ig-synthesis and proliferative activity in multiple myeloma are stimulated by different growth factors. Br. J. Haematol 1991; 79: 589–594
   PubMed Web of Science ®Google Scholar
• Tanabe O., Kawano M., Tanaka H., Iwato K., Asaoku H., Ishikawa H., Nobuyoshi M., Hirano T., Kishimoto T., Kuramoto A. BSF-2/IL-6 does not augment Ig secretion but stimulates proliferation in myeloma cells. Am. J. Hematol 1989; 31: 258–262
   PubMed Web of Science ®Google Scholar
• Herrmann F., Andreeff M., Gruss H. J., Brach M. A., Lubbert M., Mertelsmann R. Interleukin-4 inhibits growth of multiple myeloma by suppressing interleukin-6 expression. Blood 1991; 78: 2070–2074
   PubMed Web of Science ®Google Scholar
• Taylor C. W., Grogan T. M., Salmon S. E. Effects of interleukin-4 on the in vitro growth of human lymphoid and plasma cell neoplasms. Blood 1990; 75: 1114–1118
   PubMed Web of Science ®Google Scholar
• Famularo G., Giacomelli R., Di Giovanni S., Sacchetti S., Tonietti G. Cytokine production in patients with monoclonal gammopathies. J. Clini. Lab. Immunol 1991; 34: 63–69
   PubMedGoogle Scholar
• Barlogie B., Epstein J., Selvanayagam P., Alexanian R. Plasma cell myeloma. New biological insights and advances in therapy. Blood 1989; 73: 865–879
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F., Gregoretti M. G., Ghia P., Bergui L. In vitro growth of human multiple myeloma: Implications for biology and therapy. Hematol. Oncol. Clin. North. Am 1992; 6: 257–271
   PubMed Web of Science ®Google Scholar
• Bergui L., Schena M., Gaidano G, Riva M., Caligalis-Cappio F. Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma. J. Exp. Med 1989; 170: 613–618
   PubMed Web of Science ®Google Scholar
• Tokumine Y., Nishimori Y., Shibayama H., Shibano M., Tagawa S., Machii T., Kitani T. Failure of IL-3 plus IL-6 to induce the proliferation and differentiation of malignant plasma cell precursors from peripheral blood in multiple myeloma. Leukemia 1993; 7: 333–335
   PubMed Web of Science ®Google Scholar
• Goto H., Shimazaki C., Ashihara E., Ohkawa K., Oku N., Inaba T., Murakami S., Fujita N., Nakagawa M. Effects of interleukin-3 and interleukin-6 on peripheral blood cells from multiple myeloma patients and their clinical significance. Acta Haematol 1992; 88: 129–135
   PubMed Web of Science ®Google Scholar
• Klein B., Zhang X. G., Lu Z. Y., Bataille R. Interleukin-6 in human multiple myeloma. Blood 1995; 85: 863–872
   PubMed Web of Science ®Google Scholar
• Stewart A. K., Schwartz R. S. Immunoglobulin V regions and the B cell. Blood 1994; 83: 1717–1730
   PubMed Web of Science ®Google Scholar
• Witzig T., Gonchoroff N., Katzmann J., Therneau T., Kyle R., Greipp P. Peripheral blood labeling indices are a measure of disease activity in patients with monoclonal gammopathies. J. Clin. Oncol 1988; 6: 1041–1046
   PubMed Web of Science ®Google Scholar
• Witzig T. E., Gonchoroff N. J., Ahmann G. A., Katzmann J. A., Greipp P. R. T cell depletion using anti-CD2-coated magnetic beads simplifies the detection of peripheral blood plasma cells. J. Immunol. Methods 1991; 144: 253–256
   PubMed Web of Science ®Google Scholar
• Witzig T. E., Kyle R. A., Greipp P. R. Circulating peripheral blood plasma cells in multiple myeloma. Curr. Top. Microbiol. Immunol 1992; 182: 195–199
   PubMedGoogle Scholar
• Jensen G. S., Mant M. J., Belch A. J., Berenson J. R., Ruether B. A., Pilarski L. M. Selective expression of CD45 iso-forms defines CALLA+ monoclonal B lineage cells in peripheral blood from myeloma patients as late stage B cells. Blood 1991; 78: 711–719
   PubMed Web of Science ®Google Scholar
• Corradini P., Boccadoro M., Voena C., Pileri A. Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C μ sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas. J. Exp. Med 1993; 178: 1091–1096
   PubMed Web of Science ®Google Scholar
• Barlogie B., Alexanian R., Pershouse M., Smallwood L., Smith L. Cytoplasmic immunoglobulin content in multiple myeloma. J. Clin. Invest 1985; 76: 765–769
   PubMed Web of Science ®Google Scholar
• Potter M. Perspectives on the origins of multiple myeloma and plasmacytomas in mice. Hematol. Oncol. Clin. North. Am 1992; 6: 211–223
   PubMed Web of Science ®Google Scholar
• Epstein J. H., Xiao H. Q., He X. Y. Markers of multiple hematopoietic-cell lineages in multiple myeloma. N. Engl. J. Med 1990; 322: 664–668
   PubMed Web of Science ®Google Scholar
• Billadeau D., Ahmann G., Greipp P., van Ness B. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J. Exp. Med 1993; 178: 1023–1031
   PubMed Web of Science ®Google Scholar
• Zhang X. G., Gaillard J. P., Robillard N., Lu Z. Y., Gu Z. J., Jourdan M., Boiron J. M., Bataille R., Klein B. Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood 1994; 83: 3654–3663
   PubMed Web of Science ®Google Scholar
• Bakkus M. H. C., Heirman C., van Riet I., van Camp B., Thielemans K. Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood 1992; 80: 2326–2335
   PubMed Web of Science ®Google Scholar
• Pilarski L. M., Belch A. R. Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma. Blood 1993; 83: 724–736
   Web of Science ®Google Scholar
• Vescio R. A., Hong C. H., Cao J., Kim A., Schiller G. J., Lichtenstein A. K., Berenson R. J., Berenson J. R. The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma. Blood 1994; 84: 3283–3290
   PubMed Web of Science ®Google Scholar
• Freeman C., Berg J. W., Cutler S. Occurrence and prognosis of extranodal lymphoma. Cancer 1972; 29: 252–260
   PubMed Web of Science ®Google Scholar
• Reddy S., Pellettiere E., Sayena V., Hendrickson F. R. Extranodal non-Hodgkin's lymphoma. Cancer 1980; 46: 1925–1931
   PubMed Web of Science ®Google Scholar
• Economopoulos T., Alexopoulos C., Stathakis N., Styloyannis S., Dervenoulas J., Tsussis S., Raptis S. Primary gastric lymphoma. The experience of a general hospital. Br. J. Cancer 1985; 52: 391–397
   PubMed Web of Science ®Google Scholar
• Salem P., Anaissie E., Allam C., Geha S., Hashimi L., Ibrahim N., Jabbour J., Habboubi N., Khalyl M. Non-Hodgkin's lymphomas in the Middle East: A study of 417 patients with emphasis on special features. Cancer 1986; 58: 1162–1166
   PubMed Web of Science ®Google Scholar
• Otter R., Gerrits W. B. J., Sandt M. M. V. D., Hermans J., Willemze R. Primary extranodal and nodal non-Hodgkin's lymphoma. Eur. J. Clin. Oncol 1989; 25: 1203–1210
   PubMedGoogle Scholar
• D'Amore F., Christensen B. E., Brincker H., Pedersen N. T., Thorling K., Hastrup J., Pedersen M., Jensen M. K., Johansen P., Andersen E., Bach B., Sorensen E. Clinicopathological features and prognostic factors in extranodal non-Hodgkin's lymphomas. Eur. J. Cancer 1991; 27: 1201–1208
   PubMed Web of Science ®Google Scholar
• Economopoulos T., Asprou N., Stathakis N., Fountzilas G., Pavlidis N., Papaspyrou S., Dervenoulas J., Belia M., Papageorgiou S., Theoharis D., Vrettou E., Raptis S. Primary extranodal non-Hodgkin's lymphoma of the head and neck. Oncology 1992; 49: 484–488
   PubMed Web of Science ®Google Scholar
• Morton J. E., Leyland M. J., Vaughan Hudson B., Anderson L., Bennett M. H. MacLennan. Primary gastrointestinal non-Hodgkin's lymphoma: A review of 175 British National lymphoma investigation cases. Br. J. Cancer 1993; 67: 776–782
   PubMed Web of Science ®Google Scholar
• Rudders R. A., Ross M. E., DeLellis R. A. Primary extranodal lymphoma. Response to treatment and factors influencing prognosis. Cancer 1978; 42: 406–416
   PubMed Web of Science ®Google Scholar
• Non Hodgkin's Lymphoma Pathological Classification Project. National cancer institute sponsored study of classification of non-Hodgkin's lymphomas. Summary and description of a Working Formulation for clinical use. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• Carbone P., Kaplan H., Musshoff K., Smithers D. W., Tubiana M. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971; 31: 1860–1861
   PubMed Web of Science ®Google Scholar
• Fisher R. J., Longo D. L., DeVita V. T., Hubbard S. M., Miller T. P., Young R. C. Long term follow up of ProMACE-CytaBOM in non-Hodgkin's lymphomas. An. Oncol 1991; 2: 33–35, (Supp)
   PubMed Web of Science ®Google Scholar
• Banfi A., Bonadonna G., Carnevale G., Oldini C., Salisni E. Preferential sites of involvement and spread in malignant lymphoma. Eur. J. Clin. Oncol 1968; 4: 319–324
   Google Scholar
• Modan B., Shani M., Goldman H., Modan M. Nodal and extranodal malignant lymphoma in Israel: an epidemiological study. Br. J. Haematol 1969; 16: 53–59
   PubMed Web of Science ®Google Scholar
• Saprel S. C., Paydas S., Tuncer I, Varinli S., Koksal M., Akoglu T. Non-Hodgkin's lymphomas in Turkey. Cancer 1988; 62: 1653–1657
   PubMed Web of Science ®Google Scholar
• Levine A. M. Acquired immunodeficiency syndrome related lymphoma. Blood 1992; 80: 8–20
   PubMed Web of Science ®Google Scholar
• D'Amore F., Brincker H., Gronbaek K., Thorling K., Pedersen M., Jensen M. K., Andersen E., Pedersen N. T., Mortensen L. S. Non-Hodgkin's lymphoma of the gastrointestinal tract: A population-based analysis of incidence, geographic distribution, clinicopathologic presentation, features and prognosis. J. Clin. Oncol 1994; 12: 1673–1684
   PubMed Web of Science ®Google Scholar
• Papadimitriou C. S., Papacharalampous N. X., Kittas C. Primary gastrointestinal malignantlymphomas. A morphologic and immunohistochemical study. Cancer 1985; 55: 870–879
   PubMed Web of Science ®Google Scholar
• Advani S. H., Iyer R. S., Gopal R., Nair G. N., Saikia T., Dinshaw K. A., Kurkure P. A., Pai S. K. Multifocal extranodal lymphomas: An expression of homing phenomenon. Oncology 1990; 47: 334–338
   PubMed Web of Science ®Google Scholar
• Ree H. J., Rege V. B., Knisley R. E., Thayler W. R., D'Amico R. P., Song J. Y., Crowley J. P. Malignant lymphoma of Waldeyer's ring following gastrointestinal lymphoma. Cancer 1980; 46: 1528–1535
   PubMed Web of Science ®Google Scholar
• Duncan P. R., Checa F., Gowing F. C., McElwain T. J., Peckham M. J. Extranodal non-Hodgkin's lymphoma presenting in the testicle. Cancer 1980; 45: 1578–1584
   PubMed Web of Science ®Google Scholar
• Isaacson P. G., Wright D. H. Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer 1984; 53: 2515–2524
   PubMed Web of Science ®Google Scholar
• Isaacson P. G., Spencer J. Malignant lymphoma of mucosal-associated lymphoid tissue. Histopathology 1987; 11: 445–462
   PubMed Web of Science ®Google Scholar
• Isaacson P. G. Lymphomas of mucosa-associated lymphoid tissue (MALT). Commentary. Histopathology 1990; 16: 617–619
   PubMed Web of Science ®Google Scholar